|
ANRO Alto Neuroscience Inc 1999480 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-26,237,000.00 |
| Balance Sheet |
|
Current Assets
|
$269,126,000.00 |
|
Assets
|
$276,259,000.00 |
|
Current Liabilities
|
$13,115,000.00 |
|
Liabilities
|
$32,890,000.00 |
|
Equity
|
$243,369,000.00 |
|
Shares Out
|
35052731.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-27,091,000.00 |
|
Investing Cash Flow
|
$-556,000.00 |
| Market Analysis |
Market Cap
|
$1,003,559,688.53 |
|
Price
|
$26.04 |
|
BVPS
|
6.94 |
|
PB
|
4.13 |
|
EPS
|
-0.80 |
|
FCF
|
$-27,647,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:23 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-2.19 |
|
|
2026-05-13 |
-0.80 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.65 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.52 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANRO documents filed with the SEC.
ANRO Filings
Clear
